7/23/2013

The FDA has granted Lupin Pharmaceuticals approval for its metformin hydrochloride extended release tablets in 500 mg and 1000 mg strengths to boost glucose control in patients with type 2 diabetes. The drug is a generic version of Santarus' Glumetza HCl ER Tablets.

Related Summaries